Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-18038683 for Cognitive Impairment in Bipolar Disorder
NCT02466685Phase 2Completed
- Start
- Sep 2015
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JNJ-18038683 in bipolar disorder (BD). Started Sep 2015; status: completed.
02
Drugs
JNJ-18038683
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02466685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02466685.